Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Shi Yong Zhou"'
Autor:
Ping Wang, Xianhuo Wang, Kai Fu, Zheng Song, Li Hua Qiu, Zheng Zi Qian, Hui Lai Zhang, Ling Zhe Kong, Bin Meng, Xiao Hui Jia, Lan Fang Li, Xian Ming Liu, Shi Yong Zhou, Xiu Bao Ren
Publikováno v:
Translational Cancer Research. 6:746-754
Background: Double-hit lymphoma (DHL) is a rare high-grade B-cell lymphoma characterized by MYC and Bcl-2 or Bcl-6 gene translocations. The treatment of DHL remains a substantial clinical challenge due to remarkably undesirable outcomes. Innovative d
Autor:
SHI-YONG ZHOU1, MEI-LIN XU2, SHAO-QING WANG3, FANG ZHANG4, LEI WANG5 yuankundu@163.com, HUA-QING WANG1 huaqingwang@yahoo.com
Publikováno v:
Oncology Letters. 2014, Vol. 7 Issue 1, p233-238. 6p.
Autor:
Hua-Qing, Wang, Yangang, Ren, Zheng-Zi, Qian, Kai, Fu, Hui-Lai, Zhang, Wei, Li, Yun, Hou, Shi-Yong, Zhou, Xi-Shan, Hao, Cong-Hua, Xie
Publikováno v:
Thoracic cancer. 3(1)
To evaluate the efficacy and safety of nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) and to investigate the association of the status of KRAS gene mutation and epiderma
Autor:
Shi Yong Zhou, Xianhuo Wang, Zheng Zi Qian, Huaqing Wang, Zheng Song, Ping Wang, Xi Shan Hao, Li Hua Qiu, Hui Lai Zhang, Jing Zhao
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 9:117-125
The purpose of this study was to investigate the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), and pharmacokinetics of ursolic acid liposomes (UAL), as a new drug, in healthy adult volunteers and patients with advanced solid tumors.All
Autor:
Zheng Zi Qian, Yangang Ren, Shi Yong Zhou, Wei Li, Yun Hou, Hui Lai Zhang, Xi Shan Hao, Kai Fu, Cong Hua Xie, Huaqing Wang
Publikováno v:
Thoracic Cancer. 3:72-78
Objective: To evaluate the efficacy and safety of nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) and to investigate the association of the status of KRAS gene mutation a
Autor:
Yuan-min Fang, De-mao Gu, Chun-liang Zhang, Chun-long Ai, Jie Chen, Shi-yong Zhou, Xia-jiang Fu
Publikováno v:
Transactions of Nonferrous Metals Society of China. 21:s637-s641
As part of the digital mine system, a real time emergency route generating algorithm for a large scale metal mine is studied. The tunnel is abstracted and mathematically described by the center line model. A series of definitions are made and the cen
Autor:
Qin, Ma, Hui-lai, Zhang, Xia, Liu, Shi-yong, Zhou, Zheng-zi, Qian, Qiong-li, Zhai, Kai, Fu, Hua-qing, Wang
Publikováno v:
Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery. 48(12)
To investigate the prognostic predictors of nasal NK/T cell lymphoma.Records of 80 patients with nasal NK/T cell lymphoma were analyzed retrospectively. The correlation between clinical and haematological factors and prognosis was analyzed with univa
Publikováno v:
Acta Seismologica Sinica. 10:417-420
The research of some theoretical Contor models of multi-scale and the numerical model of seismic spatial distribution show that the physical property of anomalies in seismic fractal spectrums is due to an increment of nonuniformity in the point set (
Autor:
Yuan-lin, Xu, Hua-qing, Wang, Zheng-zi, Qian, Zheng, Song, Shi-yong, Zhou, Hui-lai, Zhang, Li-hua, Qiu, Xian-huo, Wang, Ping, Wang
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 35(6)
To explore the prognostic value of regulatory T cells (Tregs) and M2 macrophages in diffuse large B-cell lymphoma (DLBCL) tissues.The expression of CD163 and Foxp3 was detected by immunohistochemistry in 92 cases of DLBCL, and it was statistically an
Autor:
Yun, Hou, Hua-qing, Wang, Kai, Fu, Xian-ming, Liu, Hui-lai, Zhang, Zheng-zi, Qian, Li-hua, Qiu, Wei, Li, Shi-yong, Zhou, Lan-fang, Li, Xi-shan, Hao
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 34(4)
The aim of this study was to analyze the efficacy and toxicity of RNCE regimen in the treatment of relapsed or refractory B cell non-Hodgkin's lymphoma (NHL).From January 2000 to December 2005, 46 patients with relapsed or refractory B cell NHL were